BSD Medical Reports Presentation of Cochrane Review on the Use of Hyperthermia in Cervical Cancer Treatment at ESHO 2010 Meeting

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) today reported significant clinical results from the use of hyperthermia to treat cervical cancer. The results were presented at the annual meeting of the European Society for Hyperthermic Oncology (ESHO), which was held in Rotterdam, The Netherlands, on May 19 to 21, 2010.

MORE ON THIS TOPIC